| Revenues | |
| Research and development | 1.66M |
| Selling, general and administrative | 2.58M |
| Impairment loss | |
| Total Costs and Expenses | 5.99M |
| Loss from Operations | |
| Interest expense | |
| Interest income | |
| Realized gain on investments | |
| Realized gain (loss) on forward contracts | |
| Foreign currency transaction gain (loss) | |
| Total Other Income/(Expense) | 42.79K |
| Net Loss | |
| Net Loss Per Share (Basic and diluted) | -0.15 |
| Weighted Average Common Shares Outstanding (Basic and diluted) | 80.9M |